Don't Jump to a CGRP Antagonist for Migraine Prophylaxis
December 2019
Emgality (em-GAL-ih-tee, galcanezumab) will be the second biologic to PREVENT migraine in adults...after Aimovig (erenumab).
Both are calcitonin gene-related peptide blockers, or "CGRP antagonists." Blocking CGRP limits vasodilation.
They're once-monthly, self-administered subcutaneous injections.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive